المؤلفون: M. Kuznetsov S., A. Voronov V., V. Dvoryanchikov V., D. Svistov V., A. Nikitin I., М. Кузнецов С., А. Воронов В., В. Дворянчиков В., Д. Свистов В., А. Никитина И.

المصدر: Head and Neck Tumors (HNT); Том 11, № 2 (2021); 57-63 ; Опухоли головы и шеи; Том 11, № 2 (2021); 57-63 ; 2411-4634 ; 2222-1468 ; 10.17650/2222-1468-2021-11-2

مصطلحات موضوعية: endoscopic rhinosurgery, juvenile angiofibroma, pneumomediastinum, subcutaneous emphysema, diagnosis, treatment, эндоскопическая ринохирургия, ювенильная ангиофиброма, пневмомедиастинум, подкожная эмфизема, диагностика, лечение

وصف الملف: application/pdf

العلاقة: https://ogsh.abvpress.ru/jour/article/view/648/481Test; Dubey S.P., Schick B. Juvenile angiofibroma. Switzerland: Springer, 2017. DOI:10.1007/978-3-319-45343-9.; Kim J.S., Kim D.H., Jeon E.J. et al. A case of nasopharyngeal angiofibroma removed using a minimally invasive endoscopic endonasal technique. Wideochir Inne Tech Maloinwazyjne 2018;13(4):551–5. DOI:10.5114/wiitm.2018.75862.; Sciarretta V., Pasquini E., Farneti G. et al. Endoscopic sinus surgery for the treatment of vascular tumors. Am J Rhinol 2006;20(4):426–31. DOI:10.2500/ajr.2006.20.2888.; Shah S.R., Keshri A., Patadia S. et al. Stage III nasopharyngeal angiofibroma: Improving results with endoscopic-assisted midfacial degloving and modification to the Fisch staging system. J Craniomaxillofac Surg 2015;43(8):1678–83. DOI:10.1016/j.jcms.2015.07.025.; Nicolai P., Villaret A.B., Farina D. et al. Endoscopic surgery for juvenile angiofibroma: a critical review of indications after 46 cases. Am J Rhinol Allergy 2010;24(2):67–72. DOI:10.2500/ajra.2010.24.3443.; Huang Y., Liu Z., Want J. et al. Surgical management of juvenile nasopharyngeal angiofibroma: analysis of 162 cases from 1995 to 2012. Laryngoscope 2014;124(8):1942–6. DOI:10.1002/lary.24522.; Godoy M.D., Bezerra T.F., Pinna F. de R., Voegels R.L. Complications in the endoscopic and endoscopic-assisted treatment of juvenile nasopharyngeal angiofibroma with intracranial extension. Braz J Otorhinolaryngol 2014;80(2):120–5. DOI:10.5935/1808-8694.201.; Ardehali M.M., Samimi Ardestani S.H., Yazdani N. et al. Endoscopic approach for excision of juvenile nasopharyngeal angiofibroma: complications and outcomes. Am J Otolaryngol 2010;31(5):343–9. DOI:10.1016/j.amjoto.2009.04.007.; Nersesyan M., Kapitanov D., Lopatin A. Our experience in endoscopic management of relapsed juvenile nasal angiofibroma. Eur Arch Otolaryngol 2009;266:1076–77. DOI:10.1007/s00405-009-0987-7.; Leong S.C. A systematic review of surgical outcomes for advanced juvenile nasopharyngeal angiofibroma with intracranial involvement. Laryngoscope 2013;123(5):1125–31. DOI:10.1002/lary.23760.; Liu K., Husain Q., Kanumuri V. et al. Endoscopic graduated multiangle, multicorridor resection of juvenile nasopharyngeal angiofibroma: an individualized, tailored, multicorridor, skull base approach. J Neurosurg 2016;124(5):1328–38. DOI:10.3171/2014.1.; Liu Z., Hua W., Zhang H. et al. The risk factors for residual juvenile nasopharyngeal angiofibroma and the usual residual sites. Am J Otolaryngol 2019;40(3):343–6. DOI:10.1016/j.amjoto.2018.11.010.; Rong Z., Zixiang Y., Chang L. et al. Lacrimal hyposecretion: a surgical complication of juvenile nasopharyngeal angiofibroma. Am J Otolaryngol 2008;29(6):367–71. DOI:10.1016/j.amjoto.2007.10.006.; Hillel A.T., Metzinger R.C., Nemechek A.J., Nuss D.W. Loss of reflex tearing: an expected consequence of juvenile nasopharyngeal angiofibroma. Otolaryngol Head Neck Surg 2005;133(4):605–10. DOI:10.1016/j.otohns.2005.05.014.; Eloy P., Bachy V., Grulois V., Bertrand B. Pyocele of the lachrymal sac: A late and unusual complication after surgery for a juvenile nasopharyngeal angiofibroma. Clin Ophthalmol 2008;2(1):211–15. DOI:10.2147/opth.s2280.; Sharma S.B., Janakiram T.N., Baxi H., Chinnasamy B. Trigeminocardiac reflex during endoscopic juvenile nasopharyngeal angiofibroma surgery: an appraisal. Eur Arch Otorhinolaryngol 2017;274(7):2779–84. DOI:10.1007/s00405-017-4521-z.; Alomari A.I., Alzoubi F.Q., Khatatbeh A. A case report of unusual pneumomediastinum after endoscopic sinus surgery. Int J Surg Case Rep 2016;29:249–53. DOI:10.1016/j.ijscr.2016.11.028.; Aswani B., Anand S., Amarnath M., Lailu M. Bilateral pneumothorax, pneumomediastinum and subcutaneous emphysema following functional endoscopic sinus surgery under general anaesthesia: A case report. JMSCR 2020;8(2):933–7.; Респираторная медицина: руководство: в 3 т. Под ред. А.Г. Чучалина. 2-е изд. М.: Литтерра, 2017. Т. 2. 544 с.; Saravakos P., Taxeidis M., Kastanioudakis I., Reichel O. Subcutaneous emphysema as a complication of tonsillectomy: a systematic literature review and case report. Iran J Otorhinolaryngol 2018;30(96):3–10.; Sohail M.A., Kishore K., Stammberger H. et al. Mediastinal emphysema associated with functional endoscopic sinus surgery. A case report. Rhinology 1995;33(2):111–2.; Park J.M., Park Y.C., Lee J.N. et al. Pneumomediastinum after functional endoscopic sinus surgery under general anesthesia: A case report. Korean J Anesthesiol 2013;64(4):367–72. DOI:10.4097/kjae.2013.64.4.367.; Карпищенко С.А., Белдовская Н.Ю., Баранская С.В., Карпов А.А. Офтальмологические осложнения функциональной эндоскопической хирургии околоносовых пазух. Офтальмологические ведомости 2017;10(1):87–92. DOI:10.17816/OV1087-92.; Rubinstein A., Riddell C.E., Akram I. et al. Orbital emphysema leading to blindness following routine functional endoscopic sinus surgery. Arch Ophthalmol 2005;123(10):1452. DOI:10.1001/archopht.123.10.1452.; Sanu A., Jayanthi N.V., Mohan A.R. Pre-vertebral surgical emphysema following functional endoscopic sinus surgery. J Laryngol Otol 2006;120(11):e38. DOI:10.1017/S0022215106003288.; Bellamy M.C., Berridge J.C., Hussain S.S. Surgical emphysema and upper airway obstruction complicating recovery from anaesthesia. Br J Anaesth 1993;71(4):592–3. DOI:10.1093/bja/71.4.592.; Shah R.R., Thomas W.W., Naples J.G., Ruckenstein M.J. Subcutaneous emphysema and pneumomediastinum after eustachian tube balloon dilation. Otolaryngol Head Neck Surg 2018;159(1):203–5. DOI:10.1177/0194599818768519.; Alsaleh S., Alabidi A., Mohammed Gamal A. Subcutaneous emphysema and pneumomediastinum after adenoidectomy; A rare complications. Glob J Oto 2019;18(5):97–101. DOI:10.19080/GJO.2019.18.556000.; Бойко Н.В., Тюкин Ю.В., Флджян Л.Ю. Подкожная эмфизема и пневмомедиастинум – редкое осложнение тонзиллэктомии. Вестник оториноларингологии 2019;84(5):81–4. DOI:10.17116/otorino20198405181.; De Coninck L., Goderis J., Herregods N. et al. Massive pneumomediastinum with subcutaneous emphysema after elective adenotonsillectomy in children: Involvement of the Boyle-Davis mouth gag. Int J Pediatr Otorhinolaryngol 2019;122:152–4. DOI:10.1016/j.ijporl.2019.04.023.; Naha A., Akhtar N., Datta P.G., Datta A. Subcutaneous emphysema and pneumomediastinum following adenotonsillectomy: A case report. Bangladesh Med Res Counc Bull 2019;42:62–5. DOI:10.3329/bmrcb.v45i1.41810.; Ryu G., So Y.K., Seo M.Y. et al. Using the nasoseptal flap for reconstruction after endoscopic debridement of radionecrosis in nasopharyngeal carcinoma. Am J Rhinol Allergy 2018;32(1):61–5. DOI:10.2500/ajra.2018.32.4486.; Rivera-Serrano C.M., Lentz A.K., Pinheiro-Neto C., Snyderman C.H. Cadaveric study of the posterior pedicle nasoseptal flap: a novel flap for reconstruction of pharyngeal defects and velopharyngeal insufficiency. Plast Reconstr Surg 2013;132(5):1269–75. DOI:10.1097/PRS.0b013e3182a4c37b.; https://ogsh.abvpress.ru/jour/article/view/648Test

الإتاحة: https://doi.org/10.17650/2222-1468-2021-11-2-57-63Test
https://doi.org/10.17650/2222-1468-2021-11-2Test
https://doi.org/10.1007/978-3-319-45343-9Test
https://doi.org/10.5114/wiitm.2018.75862Test
https://doi.org/10.2500/ajr.2006.20.2888Test
https://doi.org/10.1016/j.jcms.2015.07.025Test
https://doi.org/10.2500/ajra.2010.24.3443Test
https://doi.org/10.1002/lary.24522Test
https://doi.org/10.5935/1808-8694.201Test
https://doi.org/10.1016/j.amjoto.2009.04.007Test

المؤلفون: M. Prokudin Yu., B. Martynov V., D. Svistov V., I. Litvinenko V., E. Imyanitov N., V. Chirsky S., S. Bushurov E., A. Yakovenko I., K. Chemodakova A., O. Klitsenko A., O. Gorustovich A., G. Medvedeva F., A. Bulatov R., М. Прокудин Ю., Б. Мартынов В., Д. Свистов В., И. Литвиненко В., Е. Имянитов Н., В. Чирский С., С. Бушуров Е., А. Яковенко И., К. Чемодакова А., О. Клиценко А., О. Горустович А., Г. Медведева Ф., А. Булатов Р.

المساهمون: This work was supported by the Ministry of Science and Higher Education of the Russian Federation (grant № 075-15-2019-1721, RFMEFI60419X0216)., Работа выполнена при поддержке Министерства науки и высшего образования Российской Федерации (проект №075-15-2019-1721, RFMEFI60419X0216).

المصدر: Siberian journal of oncology; Том 19, № 4 (2020); 59-66 ; Сибирский онкологический журнал; Том 19, № 4 (2020); 59-66 ; 2312-3168 ; 1814-4861 ; 10.21294/1814-4861-2020-19-4

مصطلحات موضوعية: epilepsy, seizure, IDH1 and IDH2 gene mutations, gliomas, glioblastoma, anaplastic astrocytoma, diffuse astrocytoma, brain tumors, эпилепсия, приступ, мутации IDH1/2, глиомы, глиобластома, анапластическая астроцитома, диффузная астроцитома, опухоли головного мозга

وصف الملف: application/pdf

العلاقة: https://www.siboncoj.ru/jour/article/view/1530/768Test; Ostrom Q.T., Gittleman H., Liao P., Vecchione-Koval T., Wolinsky Y., Kruchko C., Barnholtz-Sloan J.S. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 20102014. Neuro Oncol. 2017 Nov 6; 19(suppl_5): v1v88. doi:10.1093/neuonc/nox158.; Carson K.A., Grossman S.A., Fisher J.D., Shaw E.G. Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials. J Clin Oncol. 2007 Jun 20; 25(18): 2601–6. doi:10.1200/JCO.2006.08.1661.; Curran W.J.Jr., Scott C.B., Horton J., Nelson J.S., Weinstein A.S., Fischbach A.J., Chang C.H., Rotman M., Asbell S.O., Krisch R.E. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst. 1993 May 5; 85(9): 704–10. doi:10.1093/jnci/85.9.704.; Iwabuchi S., Bishara S., Herbison P., Erasmus A., Samejima H. Prognostic factors for supratentorial low grade astrocytomas in adults. Neurol Med Chir (Tokyo). 1999 Apr; 39(4): 273–9. doi:10.2176/nmc.39.273.; Lamborn K.R., Chang S.M., Prados M.D. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004 Jul; 6(3): 227–35. doi:10.1215/S1152851703000620.; Мартынов Б.В., Парфенов В.Е., Труфанов Г.Е., Фокин В.А., Алексеева Н.П., Цибиров А.А., Холявин А.И., Грачева П.В., Смирнов И.Б., Свистов Д.В. Прогностические факторы у больных с глиомами: симптомно-синдромальный анализ. Вестник Российской Военно- медицинской академии. 2010; 1(29): 7–14.; Lynam L.M., Lyons M.K., Drazkowski J.F., Sirven J.I., Noe K.H., Zimmerman R.S., Wilkens J.A. Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review. Clin Neurol Neurosurg. 2007; 109(7): 634–8. doi:10.1016/j.clineuro.2007.05.017.; Ozbek N., Cakir S., Gursel B., Meydan D. Prognostic significance of seizure in patients with glioblastoma multiforme. Neurol India. 2004 Mar; 52(1): 76–8.; Мацко Д.Е., Мацко М.В., Имянитов Е.Н. Нейроонкология. Практическая онкология. 2017; 18(1): 103–14.; Stockhammer F., Misch M., Helms H.J., Lengler U., Prall F., von Deimling A., Hartmann C. IDH1/2 mutations in WHO grade II astrocytomas associated with localization and seizure as the initial symptom. Seizure. 2012; 21(3): 194–7. doi:10.1016/j.seizure.2011.12.007.; Duan W.C., Wang L., Li K. IDH mutations but not TERTp mutations are associated with seizures in lower-grade gliomas. Medicine (Baltimore). 2018; 97(50): e13675. doi:10.1097/MD.0000000000013675.; Chen H., Judkins J., Thomas C., Wu M., Khoury L., Benjamin C.G., Pacione D., Golfinos J.G., Kumthekar P., Ghamsari F., Chen L., Lein P., Chetkovich D.M., Snuderl M., Horbinski C. Mutant IDH1 and seizures in patients with glioma. Neurology. 2017; 88(19): 1805–13. doi:10.1212/WNL.0000000000003911.; Phan K., Ng W., Lu V.M., McDonald K.L., Fairhall J., Reddy R., Wilson P. Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis. World Neurosurg. 2018 Mar; 111: e539-e545. doi:10.1016/j.wneu.2017.12.112.; Yang Y., Mao Q., Wang X., Liu Y., Mao Y., Zhou Q., Luo J. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy. J Clin Neurosci. 2016 Sep; 31: 56–62. doi:10.1016/j.jocn.2015.11.030.; Прокудин М.Ю., Одинак М.М., Литвиненко И.В., Мартынов Б.В., Железняк И.С., Лыткин М.В., Воронцова Д.А. Магнитно-резонансная спектроскопия при глиомах головного мозга: биологические маркеры. Неврология. Психиатрия. 2018; 1(145): 10–15.; Chen R., Ravindra V.M., Cohen A.L., Jensen R.L., Salzman K.L., Prescot A.P., Colman H. Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas. Neurosurg Focus. 2015 Mar; 38(3): E2. doi:10.3171/2015.1.FOCUS14745.; Табаков Д.В., Катаргин А.Н., Строганова А.М., Сендерович А.И., Насхлеташвили Д.Р., Киселева Н.П. Мутации изоцитратдегидрогеназ 1 и 2 и метилирование гена MGMT в глиомах. Успехи молекулярной онкологии. 2017; 4: 53–59. doi:10.17650/2313-805X-2017-4-1-53-59.; Лобанова Н.В., Шишкина Л.В., Рыжова М.В., Кобяков Г.Л., Сычева Р.В., Буров С.А., Лукьянов А.В., Омарова Ж.Р. Клинические, иммуногистохимические и молекулярно-генетические факторы прогноза у больных с глиобластомой. Архив патологии. 2016; 78(4): 10–19. doi:10.17116/patol201678410-19.; Schittenhelm J., Mittelbronn M., Meyermann R., Melms A., Tatagiba M., Capper D. Confirmation of R132H mutation of isocitrate dehydrogenase 1 as an independent prognostic factor in anaplastic astrocytoma. Acta Neuropathol. 2011 Nov; 122(5): 651–2. doi:10.1007/s00401-011-0885-0.; https://www.siboncoj.ru/jour/article/view/1530Test

الإتاحة: https://doi.org/10.21294/1814-4861-2020-19-4-59-66Test
https://doi.org/10.21294/1814-4861-2020-19-4Test
https://doi.org/10.1093/neuonc/nox158Test
https://doi.org/10.1200/JCO.2006.08.1661Test
https://doi.org/10.1093/jnci/85.9.704Test
https://doi.org/10.2176/nmc.39.273Test
https://doi.org/10.1215/S1152851703000620Test
https://doi.org/10.1016/j.clineuro.2007.05.017Test
https://doi.org/10.1016/j.seizure.2011.12.007Test
https://doi.org/10.1097/MD.0000000000013675Test

المؤلفون: D. Averyanov A., A. Shchyogolev V., D. Svistov V., K. Babichev N., Д. Аверьянов А., А. Щеголев В., Д. Свистов В., К. Бабичев Н.

المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 7, № 4 (2018); 366-371 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 7, № 4 (2018); 366-371 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2018-7-4

مصطلحات موضوعية: refractory epileptic status, brain aneurysm clipping, continuous EEG monitoring, рефрактерный эпилептический статус, клипирование аневризмы головного мозга, непрерывный электроэнцефалографический мониторинг

وصف الملف: application/pdf

العلاقة: https://www.jnmp.ru/jour/article/view/538/606Test; https://www.jnmp.ru/jour/article/view/538/607Test; Al-Dorzi H.M., Alruwaita A.A., Marae B.O., et al. Incidence, risk factors and outcomes of seizures occurring after craniotomy for primary brain tumor resection. Neurosciences (Riyadh). 2017; 22(2): 107–113. PMID: 28416781. DOI:10.17712/nsj.2017.2.20160570.; Gokhale S., Khan S.A., Agrawal A., et al. Levetiracetam seizure prophylaxis in craniotomy patients at high risk for postoperative seizures. Asian J. Neurosurg. 2013; 8(4): 169–173. PMID: 24550999. DOI:10.4103/17935482.125658.; Wu A.S., Trinh V.T., Suki D., et al. A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J. Neurosurg. 2013; 118(4): 873–883. PMID: 23394340. DOI:10.3171/2012.12.JNS111970.; Devarajan J., Siyam A.M., Alexopoulos A.V., et al. Non-convulsive status epilepticus in the postanesthesia care unit following meningioma excision. Can. J. Anaesth. 2011; 58(1): 68–73. PMID: 21061109. DOI:10.1007/s12630-010-9405-2.; Al-Mefty O., Wrubel D., Haddad N. Postoperative nonconvulsive encephalopathic status: identification of a syndrome responsible for delayed progressive deterioration of neurological status after skull base surgery. Clinical article. J. Neurosurg. 2009; 111(5): 1062–1068. PMID: 19326988. DOI:10.3171/2008.12.JNS08418.; Аверьянов Д.А., Лукаш А.А., Прокудин М.Ю. и др. Бессудорожный эпилептический приступ при отсроченном пробуждении пациента после удаления новообразования супратенториальной локализации. Анестезиология и реаниматология. 2016; 61(2): 143–146. PMID: 27468507. DOI:10.18821/0201-7563-2016-61-2-143-146.; Jang J.H., Song K.S., Bang J.S., et al. What Should Be Considered to Cause the Early Post-Craniotomy Seizure: Antibiotics (Cefazolin) Irrigation. J. Korean Neurosurg. Soc. 2015; 58(5): 462–466. PMID: 26713147. DOI:10.3340/jkns.2015.58.5.462.; Соколова Е.Ю., Головтеев А.Л., Савин И.А. и др. Коматозное состояние, вызванное бессудорожным эпилептическим статусом в послеоперационном периоде. Журнал Вопросы нейрохирургии им. Н.Н. Бурденко. 2010; (2): 39–45. PMID: 20825081.; Hoh B.L., Nathoo S., Chi Y.Y., et al. Incidence of seizures or epilepsy after clipping or coiling of ruptured and unruptured cerebral aneurysms in the nationwide inpatient sample database: 2002–2007. Neurosurgery. 2011; 69(3): 644–650. PMID: 21499155. DOI:10.1227/NEU.0b013e31821bc46d.; Wong J.M., Ziewacz J.E., Ho A.L., et al. Patterns in neurosurgical adverse events: open cerebrovascular neurosurgery. Neurosurg. Focus. 2012; 33(5): E15. PMID: 23116095. DOI:10.3171/2012.7.FOCUS12181.; Raper D.M., Kokabi N., McGee-Collett M. The efficacy of antiepileptic drug prophylaxis in the prevention of early and late seizures following repair of intracranial aneurysms. J. Clin. Neurosci. 2011; 18(9): 1174– 1179. PMID: 21724398. DOI:10.1016/j.jocn.2010.12.042.; Zeiler F.A., Kaufmann A.M., Gillman L.M., et al. Ketamine for medically refractory status epilepticus after elective aneurysm clipping. Neurocrit. Care. 2013; 19(1): 119–124. PMID: 23702695. DOI:10.1007/s12028013-9858-6.; Trinka E., Cock H., Hesdorffer D., et al. A definition and classification of status epilepticus-Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015; 56(10): 1515–1523. PMID: 26336950. DOI:10.1111/epi.13121.; Dobesberger J., Ristić A.J., Walser G., et al. Duration of focal complex, secondarily generalized tonic-clonic, and primarily generalized tonicclonic seizures-A video-EEG analysis. Epilepsy Behav. 2015; 49: 111– 117. PMID: 25935513. DOI:10.1016/j.yebeh.2015.03.023.; Trinka E., Kälviäinen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017; 44: 65–73. PMID: 27890484. DOI:10.1016/j.seizure.2016.11.001.; Grover E.H., Nazzal Y., Hirsch L.J. Treatment of Convulsive Status Epilepticus. Curr Treat Options Neurol. 2016; 18(3): 11. PMID: 26920416. DOI:10.1007/s11940-016-0394-5.; Cook A.M., Zafar M.S., Mathias S., et al. Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion. CNS Drugs. 2016; 30(1): 71–77. PMID: 26715390. DOI:10.1007/s40263-0150304-5.; Cock H.R. ESETT Group. Established status epilepticus treatment trial (ESETT). Epilepsia. 2011; 52(Suppl 8): 50–52. PMID: 21967363. DOI:10.1111/j.1528-1167.2011.03237.x.; Brophy G.M., Bell R., Claassen J., et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012; 17(1): 3–23. PMID: 22528274. DOI:10.1007/s12028-012-9695-z.; Glauser Т., Shinnar Sh., Gloss D., et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016; 16(1): 48–61. PMID: 26900382. DOI:10.5698/15357597-16.1.48.; Krajčová A., Waldauf P., Anděl M., Duška F. Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports. Crit. Care. 2015; 19: 398–407. PMID: 26558513. DOI:10.1186/s13054-015-1112-5.; https://www.jnmp.ru/jour/article/view/538Test

الإتاحة: https://doi.org/10.23934/2223-9022-2018-7-4-366-371Test
https://doi.org/10.23934/2223-9022-2018-7-4Test
https://doi.org/10.17712/nsj.2017.2.20160570Test
https://doi.org/10.4103/17935482.125658Test
https://doi.org/10.3171/2012.12.JNS111970Test
https://doi.org/10.1007/s12630-010-9405-2Test
https://doi.org/10.3171/2008.12.JNS08418Test
https://doi.org/10.18821/0201-7563-2016-61-2-143-146Test
https://doi.org/10.3340/jkns.2015.58.5.462Test
https://doi.org/10.1227/NEU.0b013e31821bc46dTest

المؤلفون: D. Averyanov A., R. Lakotko S., A. Shchyogotev V., D. Svistov V., K. Babichev N., G. Gavrilov V., Д. Аверьянов А., Р. Лакотко С., Д. Свистов В., А. Щеголев В., К. Бабичев Н., Г. Гаврилов В.

المصدر: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 8, № 2 (2019); 138-144 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 8, № 2 (2019); 138-144 ; 2541-8017 ; 2223-9022 ; 10.23934/2223-9022-2019-8-2

مصطلحات موضوعية: sitting position, head-up position, venous air embolism, jugular bulb pressure, transesophageal echocardiography, положение сидя, положение с приподнятой головой, венозная воздушная эмболия, давление в луковице яремной вены, чреспищеводная эхокардиография

وصف الملف: application/pdf

العلاقة: https://www.jnmp.ru/jour/article/view/631/652Test; https://www.jnmp.ru/jour/article/view/631/653Test; Baro V., Lavezzo R., Marton E., et al. Prone versus sitting position in pediatric low-grade posterior fossa tumors. Childs Nerv. Syst. 2019; 35(3): 421-428. PMID: 30610475. DOI:10.1007/s00381-018-04031-w.; Исраелян Л.А., Шиманский В.Н., Отаманов Д.А. и др. Положение больного на операционном столе в нейрохирургии: сидя или лежа. Анестезиология и реаниматология. 2013; (4): 18-26.; Porter J.M., Pidgeon C., Cunningham A.J. The sitting position in neurosurgery: A critical appraisal. Br. J. Anaesth. 1999; 82(1): 117-128. PMID: 10325848.; Choque-Velasquez J., Colasanti R., Resendiz-Nieves J.C., et al. Praying Sitting Position for Pineal Region Surgery: An Efficient Variant of a Classic Position in Neurosurgery. World Neurosurg. 2018; 113: e604-e611. PMID: 29499423. DOI:10.1016/j.wneu.2018.02.107.; Black S., Ockert D.B., Oliver W.C. Jr., Cucchiara R.F. Outcome following posterior fossa craniectomy in patients in the sitting or horizontal positions. Anesthesiology. 1988; 69(1): 49-56. PMID: 3389566.; Ganslandt O., Merkel A., Schmitt H., et al. The sitting position in neurosurgery: indications, complications and results. a single institution experience of 600 cases. Acta Neurochir. (Wien). 2013; 155(10): 18871893. PMID: 23925859. DOI:10.1007/s00701-013-1822-x.; Saladino A., Lamperti M., Mangraviti A., et al. The semisitting position: analysis of the risks and surgical outcomes in a contemporary series of 425 adult patients undergoing cranial surgery. J. Neurosurg. 2017; 127(4): 867-876. PMID: 27982770. DOI:10.3171/2016.8.JNS16719.; Eckle V.S., Neumann B., Greiner T.O., et al. Intrajugular balloon catheter reduces air embolism in vitro and in vivo. Br. J. Anaesth. 2015; 114(6): 973-978. PMID: 25835025. DOI:10.1093/bja/aev040.; Mirski M.M., Lele A.V., Fitzsimmons L., Toung Th. J. Diagnosis and Treatment of Vascular Air Embolism. Anesthesiology. 2007; 106(1): 164-177. PMID: 17197859.; Zentner J., Albrecht T., Hassler W. Prevention of an air embolism by moderate hypoventilation during surgery in the sitting position. Neurosurgery. 1991; 28(5): 705-708. PMID: 1876248.; Лубнин А.Ю., Лукьянов В.И., Осканова М.Ю. Профилактика воздушной эмболии у нейрохирургических больных, оперируемых в положении сидя: метод управляемого внутрисинусного давления. Вопросы нейрохирургии им. Н.Н. Бурденко. 1994; (4) 14-17.; Grady M.S., Bedford R.F., Park T.S. Changes in superior sagittal sinus pressure in children with head elevation, jugular venous compression, and PEEP. J. Neurosurg. 1986; 65(2): 199-202. PMID: 3522822. DOI:10.3171/jns.1986.65.2.0199.; Hibino H., Matsuura M. Cerebral Venous Sinus Pressure in Seated Dogs. Anesthesiology. 1985; 63(2): 184-189. PMID: 3896029.; Toung T., Ngeow Y.K., Long D.L., et al. Comparison of the effects of positive end-expiratory pressure and jugular venous compression on canine cerebral venous pressure Anesthesiology. 1984; 61(2): 169-172. PMID: 6380344.; Cold G.E., Juul N. Studies of Jugular Pressure. In: Cold G.E., Juul N. (eds.). Monitoring of cerebral and spinal haemodynamics during neurosurgery. Springer, Heidelberg, 2008: 289-299. DOI:10.1007/978-3-540-77873-8_22.; Meyer P-G., Cuttaree H., Charron B., et al. Prevention of venous air embolism in paediatric neurosurgical procedures performed in the sitting position by combined use of MAST suit and PEEP. Br. J. Anaesth. 1994; 73(6): 795-800. PMID: 7880669.; Аверьянов Д.А., Лакотко Р.С., Хоменко Е.А., Щеголев А.В. Встречаемость и выраженность функционирующего овального окна у пациентов нейрохирургического профиля. Анестезиология и реаниматология. 2018; (3): 54-57. DOI:10.17116/anaesthesiology201803154.; Bhardwaj A., Bhagat H., Grover V.K. Jugular venous oximetry. J. Neuroanaesth. Crit. Care. 2015; 2(3): 225-231. DOI:10.4103/2348-0548.165046.; Feigl G.C., Decker K., Wurms M., et al. Neurosurgical procedures in the semisitting position: Evaluation of the risk of paradoxical venous air embolism in patients with a patent foramen ovale. World Neurosurg. 2014; 81(1): 159-164. DOI:10.1016/j.wneu.2013.01.003.; Albin M.S., Carroll R.G., Maroon J.C. Clinical considerations concerning detection of venous air embolism. Neurosurgery. 1978; 3(3): 380-384. PMID: 740137.; Sale J.P. Prevention of air embolism during sitting neurosurgery. Anaesthesia. 1984; 39(8): 795-799. PMID: 6476317.; Colohan A.R., Perkins N.A., Bedford R.F., Jane J.A. Intravenous fluid loading as prophylaxis for paradoxical air embolism. J. Neurosurg. 1985; 62(6): 839-842. PMID: 3998832. DOI:10.3171/jns.1985.62.6.0839.; Toung T.J.K., Alano J., Nagel E.L. Effects of mast suit on central venous pressure in the sitting position. Anesthesiology. 1980; 53(3): S188.; Voorhies R.M., Fraser R.A., Van Poznak A. Prevention of air embolism with positive end expiratory pressure. Neurosurgery. 1983; 12(5): 503-506. PMID: 6346132.; Toung T.J., Aizawa H., Traystman R.J. Effects of positive end-expiratory pressure ventilation on cerebral venous pressure with head elevation in dogs. J. Appl. Physiol. 2000; 88(2): 655-661. PMID: 10658034. DOI:10.1152/jappl.2000.88.2.655.; Giebler R., Kollenberg B., Pohlen G., Peters J. Effect of Positive End-Expiratory Pressure on the Incidence of Venous Air Embolism and on the Cardiovascular Response to the Sitting Position During Neurosurgery. Br. J. Anaesth. 1998; 80(1): 30-35. PMID: 9505774.; https://www.jnmp.ru/jour/article/view/631Test

الإتاحة: https://doi.org/10.23934/2223-9022-2019-8-2-138-144Test
https://doi.org/10.23934/2223-9022-2019-8-2Test
https://doi.org/10.1007/s00381-018-04031-wTest
https://doi.org/10.1016/j.wneu.2018.02.107Test
https://doi.org/10.1007/s00701-013-1822-xTest
https://doi.org/10.3171/2016.8.JNS16719Test
https://doi.org/10.1093/bja/aev040Test
https://doi.org/10.3171/jns.1986.65.2.0199Test
https://doi.org/10.1007/978-3-540-77873-8_22Test
https://doi.org/10.17116/anaesthesiology201803154Test

المؤلفون: G. Gavrilov V., A. Stanishevskiy V., B. Gaydar V., D. Svistov V., B. Adleyba G., Г. Гаврилов В., А. Станишевский В., Б. Гайдар В., Д. Свистов В., Б. Адлейба Г.

المصدر: Diagnostic radiology and radiotherapy; № 4 (2018); 5-12 ; Лучевая диагностика и терапия; № 4 (2018); 5-12 ; 2079-5343 ; 10.22328/2079-5343-2018-4

مصطلحات موضوعية: idiopathic normal pressure hydrocephalus, diagnostics, radiology, Hakim-Adams syndrome, magnetic resonance imaging, ventricles, Evans index, DESH, callosal angle, prognosis, ventriculoperitoneal shunting, идиопатическая нормотензивная гидроцефалия, лучевая диагностика, магнитно-резонансная отмография, синдром Хакима-Адамса, желудочки головного мозга, индекс Эванса, DESH-синдром, каллезный угол, предиктор, прогностический фактор, вентрикулоперитонеальное шунтирование

وصف الملف: application/pdf

العلاقة: https://radiag.bmoc-spb.ru/jour/article/view/336/293Test; Del Brutto O.H., Mera R.M., Gladstone D., Sarmiento-Bobadilla M., Cagino K., Zambrano M., Costa A.F., Sedler M.J. Inverse relationship between the evans index and cognitive performance in nondisabled, stroke-free, community-dwelling older adults. A population-based study // Clin. Neurol. Neurosurg. 2018. Vol. 169. P. 139–143. doi:10.1016/j.clineuro.2018.03.021.; Hakim S. Some observations on CSF pressure: hydrocephalic syndrome in adults with «normal» CSF pressure [thesis in Spanish] // Javeriana University School of Medicine. 1964. Thesis No. 957. P. 1–40.; Adams R.D., Fisher C.M., Hakim S., Ojemann R.G., Sweet W.H. Symptomatic occult hydrocephalus with «normal» cerebrospinal fluid pressure: a treatable syndrome // N. Engl. J. Med. 1965. Vol. 273. P. 117–126.; Tisell M., Höglund M., Wikkelsø C. National and regional incidence of surgery for adult hydrocephalus in Sweden // Acta Neurol Scand. 2005. Vol. 112 (2). P. 72–75.; Marmarou A., Young H.F., Aygok G.A. Estimated incidence of normal pressure hydrocephalus and shunt outcome in patients residing in assisted-living and extended-care facilities // Neurosurg Focus. 2007. Vol. 22 (4). P. 67–72.; Hiraoka K., Meguro K., Mori E. Prevalence of idiopathic normal-pressure hydrocephalus in the elderly population of a Japanese rural community // Neurol. Med. Chir. (Tokyo). 2008. Vol. 48 (5). P. 197–199.; Brean A., Eide P.K. Prevalence of probable idiopathic normal pressure hydrocephalus in a Norwegian population // Acta Neurol. Scand. 2008. Vol. 118 (1). P. 48–53. doi:10.1111/j.1600–0404.2007.00982.x.; Lemcke J., Stengel D., Stockhammer F., Güthoff C., Rohde V., Meier U. Nationwide Incidence of Normal Pressure Hydrocephalus (NPH) Assessed by Insurance Claim Data in Germany // Open. Neurol. J. 2016. Vol. 10. P. 15–24. doi:10.2174/1874205X01610010015.; Jaraj D., Rabiei K., Marlow T., Jensen C., Skoog I., Wikkelsø C. Prevalence of idiopathic normal-pressure hydrocephalus // Neurology. 2014. Vol. 82 (16). P. 1449–1454. doi:10.1212/WNL.0000000000000342.; Kameda M., Yamada S., Atsuchi M., Kimura T., Kazui H., Miyajima M., Mori E., Ishikawa M., Date I., SINPHONI and SINPHONI-2 Investigators. Cost-effectiveness analysis of shunt surgery for idiopathic normal pressure hydrocephalus based on the SINPHONI and SINPHONI-2 trials // Acta Neurochir (Wien). 2017. Vol. 159 (6). P. 995–1003. doi:10.1007/s00701-017-3115-2.; Mori E., Ishikawa M., Kato T., Kazui H., Miyake H., Miyajima M., Nakajima M., Hashimoto M., Kuriyama N., Tokuda T., Ishii K., Kaijima M., Hirata Y., Saito M., Arai H.; Japanese Society of Normal Pressure Hydrocephalus. Guidelines for management of idiopathic normal pressure hydrocephalus: second edition // Neurol. Med. Chir. (Tokyo). 2012. Vol. 52 (11). P. 775–809.; Klinge P., Marmarou A., Bergsneider M., Relkin N., Black P.M. Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patients // Neurosurgery. 2005. Vol. 57. P. 40–52.; Evans W.A. J. An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy // Arch. Neurol. Psychiatry. 1942. Vol. 47. P. 931–937.; Jaraj D., Rabiei K., Marlow T., Jensen C., Skoog I., Wikkelsø C. Estimated ventricle size using Evans index: reference values from a population-based sample // Eur. J. Neurol. 2017. Vol. 24 (3). P. 468–474. doi:10.1111/ene.13226.; Kitagaki H., Mori E., Ishii K., Yamaji S., Hirono N., Imamura T. CSF Spaces in Idiopathic Normal Pressure Hydrocephalus: Morphology and Volumetry // AJNR Am. J. Neuroradiol. 1998. Vol. 19. P. 1277–1284.; Sasaki M., Honda S., Yuasa T., Iwamura A., Shibata E., Ohba H. Narrow CSF space at high convexity and high midline areas in idiopathic normal pressure hydrocephalus detected by axial and coronal MRI // Neuroradiology. 2008. Vol. 50 (2). P. 117–122.; Narita W., Nishio Y., Baba T., Iizuka O., Ishihara T., Matsuda M., Iwasaki M., Tominaga T., Mori E. High-Convexity Tightness Predicts the Shunt Response in Idiopathic Normal Pressure Hydrocephalus // AJNR Am. J. Neuroradiol. 2016. Vol. 16. P. 152–157.; Shinoda N., Hirai O., Hori S., Mikami K., Bando T., Shimo D., Kuroyama T., Kuramoto Y., Matsumоto M., Ueno Y. Utility of MRIbased disproportionately enlarged subarachnoid space hydrocephalus scoring for predicting prognosis after surgery for idiopathic normal pressure hydrocephalus: clinical research // J. Neurosurg. 2017. Vol. 127 (6). P. 1436–1442. doi:10.3171/2016.9.JNS161080.; Benedetto N., Gambacciani C., Aquila F., Di Carlo D.T., Morganti R., Perrini P. A new quantitative method to assess disproportionately enlarged subarachnoid space (DESH) in patients with possible idiopathic normal pressure hydrocephalus: The SILVER index // Сlin. Neurol. Neurosurg. 2017. Vol. 158. P. 27–32. doi:10.1016/j.clineuro.2017.04.015.; Ishii K., Kanda T., Harada A., Miyamoto N., Kawaguchi T., Shimada K., et al. Clinical impact of the callosal angle in the diagnosis of idiopathic normal pressure hydrocephalus // Eur. Radiol. 2008. Vol. 18 (11). P. 2678–2683.; Le May M., New P.F. Radiological diagnosis of occult normal pressure hydrocephalus // Radiology. 1970. Vol. 96. P. 347–358.; Virhammar J., Laurell K., Cesarini K.G., Larsson E.M. Preoperative Prognostic Value of MRI Findings in 108 Patients with Idiopathic Normal Pressure Hydrocephalus // AJNR Am. J. Neuroradiol. 2014. Vol. 35 (12). P. 2311–2318.; Doubal F.N., MacLullich A.M., Ferguson K.J., Dennis M.S., Wardlaw J.M. Enlarged perivascular spaces on MRI are a feature of cerebral small vessel disease // Stroke. 2010. Vol. 41 (3). P. 450– 454. doi:10.1161/STROKEAHA.109.564914.; Жетишев Р.Р., Камчатнов П.Р., Михайлова Н.А., Иващенко Р.А. Асимптомные инфаркты головного мозга — факторы риска и когнитивные нарушения // Журнал неврологии и психиатрии им. С. С. Корсакова. 2014. Т. 114. С. 3–6. [Zhetishev R.R., Kamchatnov P.R., Mihajlova N.A., Ivashchenko R.A. Asimptomnye infarkty golovnogo mozga — faktory riska i kognitivnye narusheniya. Zhurnal nevrologii i psihiatrii im. S. S. Korsakova, 2014, Vol. 114, рр. 3–6 (In Russ.)].; Iliff J., Wang M., Liao Y., Plogg B.A., Peng W., Gundersen G.A., Benveniste H., Vates G.E., Deane R., Goldman S.A., Nagelhus E.A., Nedergaard M. A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid // Sci Transl. Med. 2012. Vol. 4 (147). P. 147. doi:10.1126/scitranslmed.3003748.; Ringstad G., Vatnehol S.A.S., Eide K. Glymphatic MRI in idiopathic normal pressure hydrocephalus // Brain. 2017. Vol. 140 (10). P. 2691–2705. doi:10.1093/brain/awx191.; Le May M., Hochberg F.H. Ventricular differences between hydrostatic hydrocephalus and hydrocephalus ex vacuo by computed tomography // Neuroradiology. 1979. Vol. 17 (4). P. 191–195.; Wikkelsö C., Andersson H., Blomstrand C., Matousek M., Svendsen P. Computed tomography of the brain in the diagnosis of and prognosis in normal pressure hydrocephalus // Neuroradiology. 1989. Vol. 31. P. 160–165.; Kockum K., Lilja-Lund O., Larsson E.M., Rosell M., Söderström L., Virhammar J., Laurell K. The idiopathic normal-pressure hydrocephalus Radscale: a radiological scale for structured evaluation // Eur. J. Neurol. 2017. Vol. 27. P. 72–79. doi:10.1111/ene.13555.; Yin L.K., Zheng J.J., Zhao L., Hao X.Z., Zhang X.X., Tian J.Q., Zheng K., Yang Y.M… Reversed aqueductal cerebrospinal fluid net flow in idiopathic normal pressure hydrocephalus // Acta Neurol. Scand. 2017. Vol. 14. P. 25–31. doi:10.1111/ane.12750.; Kamiya K., Hori M., Irie R., Miyajima M., Nakajima M., Kamagata K., Tsuruta K., Saito A., Nakazawa M., Suzuki Y., Mori H., Kunimatsu A., Arai H., Aoki S., Abe O. Diffusion imaging of reversible and irreversible microstructural changes within the corticospinal tract in idiopathic normal pressure hydrocephalus // Neuroimage Clin. 2017. Vol. 14. P. 663–671. doi:10.1016/j.nicl.2017.03.003.; Perry A., Graffeo C.S., Fattahi N., El Sheikh M.M., Cray N., Arani A., Ehman R.L., Glaser K.J., Manduca A., Meyer F.B., Huston J. Clinical Correlation of Abnormal Findings on Magnetic Resonance Elastography in Idiopathic Normal Pressure Hydrocephalus // World Neurosurg. 2017. Vol. 99. P. 695–700. doi:10.1016/j.wneu.2016.12.121.; Lundin F., Tisell A., Dahlqvist Leinhard O., Tullberg M., Wikkelsö C., Lundberg P., Leijon G. Reduced thalamic N-acetylaspartate in idiopathic normal pressure hydrocephalus: a controlled 1H-magnetic resonance spectroscopy study of frontal deep white matter and the thalamus using absolute quantification // J. Neurol. Neurosurg. Psychiatry. 2011. Vol. 82 (7). P. 772–778. doi:10.1136/jnnp.2010.223529.; Holodny A.I., George A.E., de Leon M.J., Golomb J., Kalnin A.J., Cooper P.R. Focal dilation and paradoxical collapse of cortical fissures and sulci in patients with normal-pressure hydrocephalus // J. Neurosurg. 1998. Vol. 89 (5). P. 742–747.; Svendsen P., Duru O. Visibility of the temporal horns on computed tomography // Neuroradiology. 1981. Vol. 21(3). P. 139–144.; Virhammar J., Laurell K., Cesarini K.G., Larsson E.M. The callosal angle measured on MRI as a predictor of outcome in idiopathic normal-pressure hydrocephalu // J. Neurosurg. 2014. Vol. 120 (1). P. 178–184. doi:10.3171/2013.8.JNS13575.; https://radiag.bmoc-spb.ru/jour/article/view/336Test

الإتاحة: https://doi.org/10.22328/2079-5343-2018-4-5-12Test
https://doi.org/10.22328/2079-5343-2018-4Test
https://doi.org/10.1016/j.clineuro.2018.03.021Test
https://doi.org/10.1111/j.1600Test–0404.2007.00982.x
https://doi.org/10.2174/1874205X01610010015Test
https://doi.org/10.1212/WNL.0000000000000342Test
https://doi.org/10.1007/s00701-017-3115-2Test
https://doi.org/10.1111/ene.13226Test
https://doi.org/10.3171/2016.9.JNS161080Test
https://doi.org/10.1016/j.clineuro.2017.04.015Test

المؤلفون: B. Adleyba G., G. Gavrilov V., A. Stanishevsky V., B. Gaydar V., D. Svistov V., V. Lobzin Yu., K. Kolmakova A., Б. Адлейба Г., Г. Гаврилов В., А. Станишевский В., Б. Гайдар В., Д. Свистов В., В. Лобзин Ю., К. Колмакова А.

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 11, No 1 (2019); 53-58 ; Неврология, нейропсихиатрия, психосоматика; Vol 11, No 1 (2019); 53-58 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2019-1

مصطلحات موضوعية: normal pressure hydrocephalus, Alzheimer's disease, neurodegeneration, biomarkers, beta-amyloid protein, tau protein, нормотензивная гидроцефалия, гидроцефалия нормального давления, болезнь Альцгеймера, нейродегенерация, биомаркеры, бета-амилоид, тау-протеин

وصف الملف: application/pdf

العلاقة: https://nnp.ima-press.net/nnp/article/view/1046/843Test; Adams RD, Fisher CM, Hakim S, et al. Symptomatic occult hydrocephalus with «normal» cerebrospinal fluid pressure: a treatable syndrome. N Engl J Med. 1965 Jul 15;273:117-26.; Tisell M, Hö glund M, Wikkels∅ C. National and regional incidence of surgery for adult hydrocephalus in Sweden. Acta Neurol Scand. 2005 Aug;112(2):72-5.; Marmarou A, Young HF, Aygok GA. Estimated incidence of normal pressure hydrocephalus and shunt outcome in patients residing in assisted-living and extended-care facilities. Neurosurg Focus. 2007 Apr 15;22(4):E1.; Hiraoka K, Meguro K, Mori E. Prevalence of idiopathic normal-pressure hydrocephalus in the elderly population of a Japanese rural community. Neurol Med Chir (Tokyo). 2008 May; 48(5):197-99; discussion 199-200.; Brean A, Eide PK. Prevalence of probable idiopathic normal pressure hydrocephalus in a Norwegian population. ActaNeurol Scand. 2008 Jul;118(1):48-53. doi:10.1111/j.1600-0404.2007.00982.x. Epub 2008 Jan 16.; Tanaka N, Yamaguchi S, Ishikawa H, et al. Prevalence of possible idiopathic normal-pressure hydrocephalus in Japan: the Osaki-Tajiri project. Neuroepidemiology. 2009;32(3):171-5. doi:10.1159/000186501. Epub 2008 Dec 19.; Iseki C, Kawanami T, Nagasawa H, et al. Asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on MRI (AVIM) in the elderly: a prospective study in a Japanese population. J Neurol Sci. 2009 Feb 15;277(1-2):54-7. doi:10.1016/j.jns.2008.10.004. Epub 2008 Nov 5.; Lemcke J, Stengel D, Stockhammer F, et al. Nationwide Incidence of Normal Pressure Hydrocephalus (NPH) Assessed by Insurance Claim Data in Germany. Open Neurol J. 2016 May 26;10:15-24. doi:10.2174/1874205X01610010015. eCollection 2016.; Zhang X, Medow JE, Iskandar BJ, et al. Invasive and noninvasive means of measuring intracranial pressure: a review. Physiol Meas. 2017 Jul 24;38(8):R143-R182. doi:10.1088/1361-6579/aa7256.; Greitz D. The hydrodynamic hypothesis versus the bulk fl ow hypothesis. Neurosurg Rev. 2004 Oct;27(4):299-300. Epub 2004 Jul 23.; Kazui H, Kanemoto H, Yoshiyama K, et al. Association between high biomarker probability of Alzheimer’s disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus. J Neurol Sci. 2016 Oct 15;369:236-241. doi:10.1016/j.jns.2016.08.040. Epub 2016 Aug 19.; Jaraj D, Rabiei K, Marlow T, et al. Prevalence of idiopathic normal-pressure hydrocephalus. Neurology. 2014 Apr 22;82(16): 1449-54. doi:10.1212/WNL.0000000000000342. Epub 2014 Mar 28.; Ghosh S, Lippa C. Diagnosis and prognosis in idiopathic normal pressure hydrocephalus. Am J Alzheimers Dis Other Demen. 2014 Nov; 29(7):583-9. doi:10.1177/1533317514523485. Epub 2014 Feb 18.; Kameda M, Yamada S, Atsuchi M, et al; SINPHONI and SINPHONI-2 Investigators. Cost-effectiveness analysis of shunt surgery for idiopathic normal pressure hydrocephalus based on the SINPHONI and SINPHONI-2 trials. ActaNeurochir (Wien). 2017 Jun;159(6):995- 1003. doi:10.1007/s00701-017-3115-2. Epub 2017 Mar 1.; Mihalj M, Dolic K, Kolic K, Ledenko V. CSF tap test—obsolete or appropriate test for predicting shunt responsiveness? A systemic review. J Neurol Sci. 2016 Mar 15;362:78-84. doi:10.1016/j.jns.2016.01.028. Epub 2016 Jan 22.; Jeppsson A, Zetterberg H, Blennow K, Wikkels∅ C. Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers. Neurology. 2013 Apr 9;80(15): 1385-92. doi:10.1212/WNL.0b013e31828c2fda. Epub 2013 Mar 13.; Miyajima M, Nakajima M, Ogino I, et al. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus. Eur J Neurol. 2013 Feb;20(2): 236-42. doi:10.1111/j.1468-1331.2012.03781.x. Epub 2012 Jun 4.; Ray B, Reyes PF, Lahiri DK. Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: change in CSF levels of amyloid precursor protein (APP), amyloid-beta (Aβ) peptide and phospho-tau. J Psychiatr Res. 2011 Apr;45(4):539-47. doi:10.1016/j.jpsychires.2010.07.011. Epub 2010 Sep 9.; Agren-Wilsson A, Lekman A, Sjë berg W, et al. CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand. 2007 Nov;116(5):333-9. doi:10.1111/j.1600-0404.2007.00890.x; Magdalinou N, Lees AJ, Zetterberg H. Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions. J Neurol Neurosurg Psychiatry. 2014 Oct;85(10): 1065-75. doi:10.1136/jnnp-2013-307539.; Tullberg M, Blennow K, Mansson JE, et al. Ventricular cerebrospinal fluid neurofilament protein levels decrease in parallel with white matter pathology after shunt surgery in normal pressure hydrocephalus. Eur J Neurol. 2007 Mar; 14(3):248-54. doi:10.1111/j.1468-1331.2006.01553.x; Tullberg M, Blennow K, Mansson JE, et al. Cerebrospinal fluid markers before and after shunting in patients with secondary and idiopathic normal pressure hydrocephalus. Cerebrospinal Fluid Res. 2008 Apr 25;5:9. doi:10.1186/1743-8454-5-9.; Pyykkö OT, Lumela M, Rummukainen J, et al. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus. PLoS One. 2014 Mar 17;9(3): e91974. doi:10.1371/journal.pone.0091974. eCollection 2014.; Nakajima M, Miyajima M, Ogino I, et al. Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien). 2011 Jun;153(6):1339-46; discussion 1346. doi:10.1007/s00701-011-0963-z.; Li X, Miyajima M, Mineki R, et al. Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics. Acta Neurochir (Wien). 2006 Aug; 148(8):859-64. doi:10.1007/s00701-006-0787-4.; Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 May 16;120(3):885-90.; Lins H, Wichart I, Bancher C, et al. Immunoreactivities of amyloid beta peptide (1–42) and total tau protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus. J Neural Transm (Vienna). 2004 Mar;111(3):273-80. Epub 2003 Dec 3.; Cole SL, Vassar R. The Alzheimer's disease β-secretase enzyme, BACE1. Mol Neurodegener. 2007 Nov 15;2:22.; Blennow K, Hampel H, Weiner M, Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010 Mar;6(3):131-44. doi:10.1038/nrneurol.2010.4.; Hanger DP, Seereeram A, Noble W. Mediators of tau phosphorylation in the pathogenesis of Alzheimer's disease. Expert Rev Neurother. 2009 Nov;9(11):1647-66. doi:10.1586/ern.09.104.; Picascia M, Zangaglia R, Bernini S, et al. A review of cognitive impairment and differential diagnosis in idiopathic normal pressure hydrocephalus. Funct Neurol. 2015 Oct-Dec;30(4): 217-28.; Jingami N, Asada-Utsugi M, Uemura K, et al. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease. J Alzheimers Dis. 2015;45(1):109-15. doi:10.3233/JAD-142622.; Schirinzi T, Sancesario GM, Ialongo C, et al. A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus. Front Neurol. 2015 Apr 23; 6:86. doi:10.3389/fneur.2015.00086. eCollection 2015.; Bech RA, Waldemar G, Gjerris F, et al. Shunting effects in patients with idiopathic normal pressure hydrocephalus; correlation with cerebral and leptomeningeal biopsy findings. ActaNeurochir (Wien). 1999;141(6):633-9.; Cabral D, Beach TG, Vedders L, et al. Frequency of Alzheimer's disease pathology at autopsy in patients with clinical normal pressure hydrocephalus. Alzheimers Dement. 2011 Sep; 7(5):509-13. doi:10.1016/j.jalz.2010.12.008. Epub 2011 Jul 1.; Hamilton R, Patel S, Lee EB, et al. Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol. 2010 Oct;68(4):535-40. doi:10.1002/ana.22015.; Bech-Azeddine R, H∅gh P, Juhler M, et al. Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting. J NeurolNeurosurg Psychiatry. 2007 Feb;78(2):157-61. Epub 2006 Sep 29.; Hamlat A, Sid-Ahmed S, Adn M, et al. Idiopathic normal pressure hydrocephalus: theoretical concept of a spinal etiology. Med Hypotheses. 2006;67(1):110-4. Epub 2006 Mar 7.; Schirinzi T, Sancesario GM, Di Lazzaro G, et al. Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus. J Neural Transm (Vienna). 2018 Apr; 125(4): 673-679. doi:10.1007/s00702-018-1842-z.; Sosvorova L, Vcelak J, Mohapl M, et al. Selected pro- and anti-inflammatory cytokines in cerebrospinal fluid in normal pressure hydrocephalus. Neuro Endocrinol Lett. 2014;35(7): 586-93.; Murakami Y, Matsumoto Y, Hoshi K, et al. Rapid increase of «brain-type» transferrin in cerebrospinal fluid after shunt surgery for idiopathicnormal pressure hydrocephalus: a prognosis marker for cognitive recovery. J Biochem. 2018 Sep 1;164(3):205-213. doi:10.1093/jb/mvy043.; Luikku AJ, Hall A, Nerg O, et al. Multimodal analysis to predict shunt surgery outcome of 284 patients with suspected idiopathic normal pressure hydrocephalus. ActaNeurochir (Wien). 2016 Dec;158(12):2311- 2319. Epub 2016 Oct 14.; Pfanner T, Henri-Bhargava A, Borchert S. Cerebrospinal Fluid Biomarkers as Predictors of Shunt Response in Idiopathic Normal Pressure Hydrocephalus: A Systematic Review. Can J Neurol Sci. 2018 Jan;45(1):3-10. doi:10.1017/cjn.2017.251. Epub 2017 Nov 10.; https://nnp.ima-press.net/nnp/article/view/1046Test

الإتاحة: https://doi.org/10.14412/2074-2711-2019-1-53-58Test
https://doi.org/10.14412/2074-2711-2019-1Test
https://doi.org/10.1111/j.1600-0404.2007.00982.xTest
https://doi.org/10.1159/000186501Test
https://doi.org/10.1016/j.jns.2008.10.004Test
https://doi.org/10.2174/1874205X01610010015Test
https://doi.org/10.1088/1361-6579/aa7256Test
https://doi.org/10.1016/j.jns.2016.08.040Test
https://doi.org/10.1212/WNL.0000000000000342Test
https://doi.org/10.1177/1533317514523485Test

المؤلفون: A. Savello V., D. Svistov V., K. Kurashevich G., G. Mishina A., А. Савелло В., Д. Свистов В., К. Курашевич Г., Г. Мишина А.

المصدر: Diagnostic radiology and radiotherapy; № 2 (2016); 86-92 ; Лучевая диагностика и терапия; № 2 (2016); 86-92 ; 2079-5343 ; 10.22328/2079-5343-2016-2

مصطلحات موضوعية: контраст-индуцированная энцефалопатия, контрастирующее вещество, œntrast-induced encephalopathy, contrast media

وصف الملف: application/pdf

العلاقة: https://radiag.bmoc-spb.ru/jour/article/view/128/129Test; Baik S. K. et al. Immediate CT findings following embolization of cerebral aneurysms: suggestion of blood-brain barrier or vascular permeability change // Neuroradiology.- 2008.- Vol. 50 (3).- Р. 259-266.; Yu J., Dangas G. Commentary: New insights into the risk factors of contrast-induced encephalopathy. Journal of endovascular therapy: an official journal of the International Society of Endovascular Specialists. 2011.- Vol. 18 (4).- Р. 545-546.; Junck L., Marshall W. H. Neurotoxicity of radiological contrast agents // Ann. Neurol.- 1983.- Vol. 13 (5).- Р. 469-484.; Yan J., Ramanathan V. Severe encephalopathy following cerebral arteriogram in a patient with end-stage renal disease // Seminars in dialysis.- 2013.- Vol. 26 (2).- Р 203-207.; Touhami S. et al. Everolimus-induced posterior reversible encephalopathy syndrome and bilateral optic neuropathy after kidney transplantation // Transplantation.- 2014.- Vol. 98 (12).- Р 102-104.; Nishijima H. et al. Asymmetric Posterior Reversible Encephalopathy Syndrome due to Hypertensive Encephalopathy // Internal medicine (Tokyo, Japan).- 2015.- Vol. 54 (8).- Р 993-994.; Wagih A. et al. Posterior Reversible Encephalopathy Syndrome (PRES): Restricted Diffusion does not Necessarily Mean Irreversibility // Pol. J. Radiol.- 2015.- Vol. 80.- Р 210-216.; Yafour N. et al. Cyclosporine-related brainstem atypical posterior reversible leukoencephalopathy syndrome following hematopoietic stem cell transplant // Hematol. Oncol. Stem Cell Ther.- 2015.- Apr. 28.; Guimaraens L. et al. Transient encephalopathy from angiographic contrast: a rare complication in neurointerventional procedures. Cardiovascular and interventional radiology.- 2010.- Vol. 33 (2).- Р. 383-388.; Leong S., Fanning N. F. Persistent neurological deficit from iodina-ted contrast encephalopathy following intracranial aneurysm coiling. A case report and review of the literature // Interv. Neuroradiol.- 2012.- Vol. 18 (1).- Р 33-41.; Савелло А. В. Контраст-индуцированная энцефалопатия как редкое осложнение внутрисосудистого введения контрастирующих веществ // Диагностическая и интервенционная радиология.- 2015.- Vol. 9 (4).- Р 57-61.; Law S. et al. Contrast-Induced Neurotoxicity following Cardiac Catheterization // Case Rep. Med.- 2012.- Article ID 267860.; Liao M. T. et al. Contrast-Induced Encephalopathy after Percutaneous Coronary Intervention // Acta Cardiologica Sinica.- 2013.- Vol. 7.- Р 277-280.; https://radiag.bmoc-spb.ru/jour/article/view/128Test

الإتاحة: https://doi.org/10.22328/2079-5343-2016-2-86-92Test
https://doi.org/10.22328/2079-5343-2016-2Test
https://radiag.bmoc-spb.ru/jour/article/view/128Test

المؤلفون: A. Savello V., D. Svistov V., V. Sorokoumov A., А. Савелло В., Д. Свистов В., Д. Сорокоумов А.

المصدر: Neurology, Neuropsychiatry, Psychosomatics; Vol 7, No 4 (2015); 42-49 ; Неврология, нейропсихиатрия, психосоматика; Vol 7, No 4 (2015); 42-49 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2015-4

مصطلحات موضوعية: ischemic stroke, endovascular revascularization, thrombectomy, intra-arterial thrombolysis, ишемический инсульт, внутрисосудистая реваскуляризация, тромбэктомия, интраартериальный тромболизис

وصف الملف: application/pdf

العلاقة: https://nnp.ima-press.net/nnp/article/view/558/520Test; Шамалов НА. Реперфузионная терапия при ишемическом инсульте в Российской Федерации: проблемы и перспективы. Неврология, нейропсихиатрия, психосоматика. 2014;6(2S):15-22. [Shamalov NA. Reperfusion therapy for ischemic stroke in the Russian Federation: Problems and promises. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, neuropsychiatry, psychosomatics. 2014;6(2S):15-22. (In Russ.)]. DOI: http://dx.doi.org/10.14412/2074-2711-2014-2S-15-22Test; Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013 Mar 7;368(10):893-903. doi:10.1056/NEJMoa1214300. Epub 2013 Feb 7.; Riedel CH, Zimmermann P, JensenKondering U,et al. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke. 2011 Jun;42(6):1775-7. doi:10.1161/STROKEAHA.110.609693. Epub 2011 Apr 7.; Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010 Oct;41(10):2254-8. doi:10.1161/STROKEAHA.110.592535. Epub 2010 Sep 9.; Zaidat OO, Yoo AJ, Khatri P, et al. Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke. 2013 Sep;44(9):2650-63. doi:10.1161/STROKEAHA.113.001972. Epub 2013 Aug 6.; Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999 Dec 1;282(21):2003-11.; Ogawa A, Mori E, Minematsu K, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke. 2007 Oct;38(10):2633-9. Epub 2007 Aug 16.; Lee M, Hong KS, Saver JL. Efficacy of intraarterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke. 2010 May;41(5):932-7. doi:10.1161/STROKEAHA.109.574335. Epub 2010 Apr 1.; IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004 Apr;35(4):904-11. Epub 2004 Mar 11.; Turk AS, Spiotta A, Frei D, et al. Initial clinical experience with the ADAPT technique: a direct aspiration first pass technique for stroke thrombectomy. J Neurointerv Surg. 2014 Apr 1;6(3):231-7. doi:10.1136/neurintsurg-2013-010713. Epub 2013 Apr 27.; Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013 Mar;44(3):870-947. doi:10.1161/STR.0b013e318284056a. Epub 2013 Jan 31.; Agrawal A, Golovoy D, Nimjee S, et al. Mechanical thrombectomy devices for endovascular management of acute ischemic stroke: Duke stroke center experience. Asian J Neurosurg. 2012 Oct;7(4):166-70. doi:10.4103/1793-5482.106647.; Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012 Oct 6;380(9849):1241-9. doi:10.1016/S0140-6736(12)61384-1. Epub 2012 Aug 26.; Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012 Oct 6;380(9849):1231-40. doi:10.1016/S0140-6736(12)61299-9. Epub 2012 Aug 26.; Tarr R, Hsu D, Kulcsar Z, et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J Neurointerv Surg. 2010 Dec;2(4):341-4. doi:10.1136/jnis.2010.002600.; Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015 Jan 1;372(1):11-20. doi:10.1056/NEJMoa1411587. Epub 2014 Dec 17.; Khatri P, Abruzzo T, Yeatts SD, et al. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009 Sep 29;73(13):1066-72. doi:10.1212/WNL.0b013e3181b9c847.; Goyal M, Demchuk AM, Menon BK, et al. Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke. N Engl J Med. 2015 Mar 12;372(11):1019-30. doi:10.1056/NEJMoa1414905. Epub 2015 Feb 11.; Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection. N Engl J Med. 2015 Mar 12;372(11):1009-18. doi:10.1056/NEJMoa1414792. Epub 2015 Feb 11.; Liebeskind DS, Tomsick TA, Foster LD, et al. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 2014 Mar;45(3):759-64. doi:10.1161/STROKEAHA.113.004072. Epub 2014 Jan 28.; Hill MD, Demchuk AM, Goyal M, et al. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke. 2014 Feb;45(2):444-9. doi:10.1161/STROKEAHA.113.003580. Epub 2013 Dec 12.; Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012 Oct;11(10):860-7. doi:10.1016/S1474-4422(12)70203-X. Epub 2012 Sep 4. 23. Olivot JM, Mlynash M, Inoue M, et al. Hypoperfusion intensity ratio predicts infarct progression and functional outcome in the DEFUSE 2 Cohort. Stroke. 2014 Apr;45(4):1018-23. doi:10.1161/STROKEAHA.113.003857. Epub 2014 Mar 4.; Akins PT, Amar AP, Pakbaz RS, et al. Complications of endovascular treatment for acute stroke in the SWIFT trial with solitaire and Merci devices. AJNR Am J Neuroradiol. 2014 Mar;35(3):524-8. doi:10.3174/ajnr.A3707. Epub 2013 Sep 12.; Fiorelli M, Bastianello S, von Kummer R, et al. Hemorrhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study I (ECASS I) cohort. Stroke. 1999 Nov;30(11):2280-4.; Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic Transformation of Ischemic Brain Tissue : Asymptomatic or Symptomatic? Stroke. 2001 Jun;32(6):1330-5.; Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures. A scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. J Neurointerv Surg. 2010 Jun;2(2):177-88. doi:10.1161/CIRCULATIONAHA.109.192217.; https://nnp.ima-press.net/nnp/article/view/558Test

الإتاحة: https://doi.org/10.14412/2074-2711-2015-4-42-49Test
https://doi.org/10.14412/2074-2711-2015-4Test
https://doi.org/10.14412/2074-2711-2014-2S-15-22Test
https://doi.org/10.1056/NEJMoa1214300Test
https://doi.org/10.1161/STROKEAHA.110.609693Test
https://doi.org/10.1161/STROKEAHA.110.592535Test
https://doi.org/10.1161/STROKEAHA.113.001972Test
https://doi.org/10.1161/STROKEAHA.109.574335Test
https://doi.org/10.1136/neurintsurg-2013-010713Test
https://doi.org/10.1161/STR.0b013e318284056aTest

المؤلفون: B. Martynov V., V. Parfenov Ye., D. Svistov V., G. Trufanov Ye., V. Fokin A., A. Kholyavin I., V. Nizkovolos B., Б. Мартынов В., В. Парфенов Е., Д. Свистов В., Г. Труфанов Е., В. Фокин А., А. Холявин И., В. Низковолос Б.

المصدر: Bulletin of Siberian Medicine; Том 7, № 5-1 (2008); 231-235 ; Бюллетень сибирской медицины; Том 7, № 5-1 (2008); 231-235 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2008-7-5-1

وصف الملف: application/pdf

العلاقة: https://bulletin.tomsk.ru/jour/article/view/3483/2279Test; https://bulletin.tomsk.ru/jour/article/view/3483Test

الإتاحة: https://doi.org/10.20538/1682-0363-2008-5-1-231-235Test
https://doi.org/10.20538/1682-0363-2008-7-5-1Test
https://bulletin.tomsk.ru/jour/article/view/3483Test

المؤلفون: V. Dekan S., B. Martynov V., G. Trufanov Ye., D. Svistov V., В. Декан С., Б. Мартынов В., Г. Труфанов Е., Д. Свистов В.

المصدر: Bulletin of Siberian Medicine; Том 7, № 5-1 (2008); 90-99 ; Бюллетень сибирской медицины; Том 7, № 5-1 (2008); 90-99 ; 1819-3684 ; 1682-0363 ; 10.20538/1682-0363-2008-7-5-1

وصف الملف: application/pdf

العلاقة: https://bulletin.tomsk.ru/jour/article/view/3447/2218Test; https://bulletin.tomsk.ru/jour/article/view/3447Test

الإتاحة: https://doi.org/10.20538/1682-0363-2008-5-1-90-99Test
https://doi.org/10.20538/1682-0363-2008-7-5-1Test
https://bulletin.tomsk.ru/jour/article/view/3447Test